Silverarc Capital Management »

GSK shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of GSK (GSK) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in GSK

Tip: Access up to 7 years of quarterly data

All positions including GSK held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in GSK by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2022-12-31 $4.8M 136k 35.14

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding GSK

Dodge & Cox
JTC Employer Solutions Trustee
Fisher Investments
T. Rowe Price Associates
PRIMECAP Management Company
Royal Bank of Canada
Holocene Advisors
Goldman Sachs Group
Arrowstreet Capital, Limited Partnership
Provident Trust
Equity Investment Corp Acquisition
Hotchkis and Wiley Capital Management
Wells Fargo & Company
Hsbc Holdings
Douglas Lane & Associates

View all funds holding GSK